Hotel Šport in Otočec, Slovenia, hosts the 30th Annual General Meeting of Krka, tovarna zdravil, d. d., Novo mesto today. The President of the Management Board and CEO Jože Colarič presented the key 2023 Krka Group business results and some performance estimates for the first half of this year: ‘The first half of the year, when we celebrate our 70th-anniversary, was marked with further good performance. We recorded increased sales in all our regions and most markets. Our estimates suggest that sales growth reached 7%, while estimated revenue and operating profit (EBIT) for the first half of 2024 have reached record levels since the foundation.’
The Supervisory Board is scheduled to discuss unaudited operating results of Krka and the Krka Group for the first half of 2024 at their regular meeting of 17 July. A press release is planned for the next day. Considering the performance estimate for the first half of 2024, we expect to meet our annual plans by the end of the year.
Financial highlights
€ million | Estimate | Index | |
Revenue | 985.4 | 920.4 | 107 |
– Of that revenue from contracts with customers (products and services) | 980.8 | 916.5 | 107 |
Earnings before interest, tax, depreciation and amortisation (EBITDA) | 283.7 | 288.6 | 98 |
Operating profit (EBIT) | 237.7 | 236.2 | 101 |
Net profit | 221.6 | 170.1 | 130 |
Ratios | |||
EBITDA margin | 28.8% | 31.4% | |
EBIT margin | 24.1% | 25.7% | |
Net profit margin (ROS) | 22.5% | 18.5% |
Sales
Estimated Product and Service Sales by Region
Region Slovenia,6.1 Region South-East Europe,14.0 Region East Europe,33.9 Region Central Europe,23.2 Region West Europe,18.8 Region Overseas Markets,4.0